Ying Zhao
Peking University
15 Papers
37 Citations
Ying Zhao is an academic researcher from Peking University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 4 publications. Previous affiliations of Ying Zhao include Capital Medical University.
Chat about Author
Papers
Comparisons of diabetic retinopathy events associated with glucose‐lowering drugs in patients with type 2 diabetes mellitus: A network meta‐analysis
Huilin Tang,Huilin Tang,Guangyao Li,Ying Zhao,Fei Wang,Emily W. Gower,Luwen Shi,Tiansheng Wang,Tiansheng Wang +8 more
TL;DR: In this article, the comparative effects of glucose-lowering drugs (GLDs) on the risk of diabetic retinopathy (DR) in patients with type 2 diabetes mellitus (T2DM) were assessed.
Drug-induced anaphylaxis in China: a 10 year retrospective analysis of the Beijing Pharmacovigilance Database
Ying Zhao,Shusen Sun,Xiaotong Li,Xiang Ma,Huilin Tang,Lulu Sun,Suodi Zhai,Tiansheng Wang,Tiansheng Wang +8 more
TL;DR: Wang et al. as discussed by the authors used the Beijing Pharmacovigilance Database (BPD) to identify the causes of drug-induced anaphylaxis (DIA) in Beijing, China.
Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database
TL;DR: In this paper , the authors investigated the association between tigecycline and coagulation dysfunction using the US Food and Drug Administration Adverse Event Reporting System (FAERS) database.
Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS)
Ying Zhao,Jingru Zhang,Kai Zheng,Sydney Thai,Ross J. Simpson,Alan C Kinlaw,Yang Xu,Jingkai Wei,Xiaohui Cui,John B. Buse,Til Stürmer,Tiansheng Wang +11 more
TL;DR: The use of hydroxychloroquine or chloroquine as monotherapy or combined with azithromycin for the treatment of coronavirus disease 2019 (COVID-19) may increase the risk of serious cardiovascular adverse events (SCAEs) as mentioned in this paper .
Drug-induced anaphylaxis in China: a 10 year retrospective analysis of the Beijing Pharmacovigilance Database
Ying Zhao,Shusen Sun,Xiaotong Li,Xiang Ma,Huilin Tang,Lulu Sun,Suodi Zhai,Tiansheng Wang,Tiansheng Wang +8 more
- 01 Oct 2018
TL;DR: Patients should be closely monitored for signs and symptoms of anaphylaxis when medications are administered especially with antibiotics, TCM, radiocontrast and antineoplastic agents.
13